Premium
Induction of tumor‐cell lysis by bi‐specific antibody recognizing ganglioside GD2 and T‐cell antigen CD3
Author(s) -
Bernhard Helga,
Karbach Julia,
Büschenfelde KarlHermann Meyer Zum,
Strittmatter Wolfgang,
Knuth Alexander
Publication year - 1993
Publication title -
international journal of cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.475
H-Index - 234
eISSN - 1097-0215
pISSN - 0020-7136
DOI - 10.1002/ijc.2910550324
Subject(s) - monoclonal antibody , antigen , ganglioside , lysis , antibody , cytotoxic t cell , cytotoxicity , microbiology and biotechnology , cd3 , biology , t lymphocyte , t cell , chemistry , in vitro , cd8 , immunology , immune system , biochemistry
Human tumor cells expressing ganglioside GD2 were lysed by various effector populations targeted with an anti‐CD3‐anti‐GD2 bi‐specific antibody (BAb CD3 x GD2). This antibodyheteroconjugate was prepared by chemically cross‐linking the OKT‐3 monoclonal antibody (MAb) reactive with CD3 antigen on T lymphocytes with the ganglioside MAb ME 361, which binds preferentially to the tumor‐associated ganglioside GD2. The specificity of target‐cell lysis by the cytotoxic T cells (CTL) was mediated by the specificity of the targeting antibody: GD2‐negative cells were not lysed in the presence of the CD3 x GD2 BAb. A dose‐dependent response was observed in a range of 10 to 10,000 ng/ml. In contrast, 2 other BAbs recognizing the tumor‐associated antigens EGF‐R and TKB‐2 had greater potency to mediate tumor‐cell lysis than the GD2 x CD3 BAb. Peripheral‐blood cells (PBL) stimulated with OKT‐3 MAb or with irradiated tumor cells in a mixed lymphocyte culture (MLTC) could be induced to lyse GD2‐positive tumor cells in the presence of CD3 x GD2 BAb. The tumor‐cell lysis could be mediated by autologous or allogeneic effector cells. NK cells had no influence on the BAb‐induced cytotoxicity.